{"title":"2024 年心力衰竭会议摘要更正，2024 年 5 月 11-14 日，葡萄牙里斯本。欧洲心衰杂志》。26(Suppl. 2) (2024) 246-260. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3326","authors":"","doi":"10.1002/ejhf.3521","DOIUrl":null,"url":null,"abstract":"<p>The table 1 in abstract “Length of hospital stay, re-hospitalization rates and comorbidities in patients with worsening heart failure. Data from 3 large cohort studies in the US, Germany and Japan” by A Alexander Michel, e. al. has been updated as follows.</p>\n<div>\n<div tabindex=\"0\">\n<table>\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Germany n = 47,003</th>\n<th>US n = 75,140</th>\n<th>Japan n = 9,091</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td><b>Mean age (SD), years</b></td>\n<td>78.91 (10.02)</td>\n<td>74.24 (10.88)</td>\n<td>77.55 (10.02)</td>\n</tr>\n<tr>\n<td>Female n (%)</td>\n<td>23,756 (50.5)</td>\n<td>33,968 (45.2)</td>\n<td>4,084 (44.9)</td>\n</tr>\n<tr>\n<td>Male</td>\n<td>23,247 (49.5)</td>\n<td>41,132 (54.7)</td>\n<td>5,007 (55.1)</td>\n</tr>\n<tr>\n<td><b>Comorbidities n (%)</b></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Anaemia</td>\n<td>10,297 (21.9)</td>\n<td>38,313 (51.0)</td>\n<td>3,120 (34.3)</td>\n</tr>\n<tr>\n<td>Atrial fibrillation</td>\n<td>24,574 (52.3)</td>\n<td>43,768 (58.2)</td>\n<td>3571 (39.3)</td>\n</tr>\n<tr>\n<td>CKD (any stage)</td>\n<td>19,758 (42.0)</td>\n<td>44,280 (58.9)</td>\n<td>5082 (55.9)</td>\n</tr>\n<tr>\n<td>Diabetes mellitus</td>\n<td>23,059 (49.1)</td>\n<td>44,900 (59.8)</td>\n<td>3145 (34.6)</td>\n</tr>\n<tr>\n<td>Hypertension</td>\n<td>44,660 (95.0)</td>\n<td>73,459 (97.8)</td>\n<td>7837 (86.2)</td>\n</tr>\n<tr>\n<td>Ischaemic heart disease</td>\n<td>29,715 (63.2)</td>\n<td>59,685 (79.4)</td>\n<td>5174 (56.9)</td>\n</tr>\n<tr>\n<td>Hyperkalaemia</td>\n<td>2,195 (4.7)</td>\n<td>12,000 (16.0)</td>\n<td>1029 (11.3)</td>\n</tr>\n<tr>\n<td>Stroke</td>\n<td>4,747 (10.1)</td>\n<td>10,136 (13.5)</td>\n<td>1906 (21.0)</td>\n</tr>\n<tr>\n<td>Venous thromboembolism</td>\n<td>3,697 (7.9)</td>\n<td>5105 (6.8)</td>\n<td>1,047 (11.5)</td>\n</tr>\n<tr>\n<td>Depression</td>\n<td>13,255 (28.2)</td>\n<td>21,057 (28.0)</td>\n<td>639 (7.0)</td>\n</tr>\n<tr>\n<td>Respiratory infection</td>\n<td>13,616 (29.0)</td>\n<td>36,697 (48.8)</td>\n<td>3,711 (40.8)</td>\n</tr>\n<tr>\n<td>Hypothyroidism</td>\n<td>8,678 (18.5)</td>\n<td>20,420 (27.2)</td>\n<td>1,001 (11.0)</td>\n</tr>\n<tr>\n<td>COPD</td>\n<td>15,738 (33.5)</td>\n<td>35,363 (47.1)</td>\n<td>1711 (18.8)</td>\n</tr>\n<tr>\n<td>Myocardial infarction</td>\n<td>10,300 (21.9)</td>\n<td>30,145 (40.1)</td>\n<td>1798 (19.8)</td>\n</tr>\n<tr>\n<td>Cancer</td>\n<td>9604 (20.4)</td>\n<td>11,763 (15.7)</td>\n<td>2,091 (23.0)</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div></div>\n</div>\n<p>We apologize for this error.</p>","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":"12 1","pages":""},"PeriodicalIF":16.9000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Abstracts of the Heart Failure 2024, 11-14 May 2024, Lisbon, Portugal. European Journal of Heart Failure. 26(Suppl. 2) (2024) 246-260. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3326\",\"authors\":\"\",\"doi\":\"10.1002/ejhf.3521\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The table 1 in abstract “Length of hospital stay, re-hospitalization rates and comorbidities in patients with worsening heart failure. Data from 3 large cohort studies in the US, Germany and Japan” by A Alexander Michel, e. al. has been updated as follows.</p>\\n<div>\\n<div tabindex=\\\"0\\\">\\n<table>\\n<thead>\\n<tr>\\n<th>Characteristics</th>\\n<th>Germany n = 47,003</th>\\n<th>US n = 75,140</th>\\n<th>Japan n = 9,091</th>\\n</tr>\\n</thead>\\n<tbody>\\n<tr>\\n<td><b>Mean age (SD), years</b></td>\\n<td>78.91 (10.02)</td>\\n<td>74.24 (10.88)</td>\\n<td>77.55 (10.02)</td>\\n</tr>\\n<tr>\\n<td>Female n (%)</td>\\n<td>23,756 (50.5)</td>\\n<td>33,968 (45.2)</td>\\n<td>4,084 (44.9)</td>\\n</tr>\\n<tr>\\n<td>Male</td>\\n<td>23,247 (49.5)</td>\\n<td>41,132 (54.7)</td>\\n<td>5,007 (55.1)</td>\\n</tr>\\n<tr>\\n<td><b>Comorbidities n (%)</b></td>\\n<td></td>\\n<td></td>\\n<td></td>\\n</tr>\\n<tr>\\n<td>Anaemia</td>\\n<td>10,297 (21.9)</td>\\n<td>38,313 (51.0)</td>\\n<td>3,120 (34.3)</td>\\n</tr>\\n<tr>\\n<td>Atrial fibrillation</td>\\n<td>24,574 (52.3)</td>\\n<td>43,768 (58.2)</td>\\n<td>3571 (39.3)</td>\\n</tr>\\n<tr>\\n<td>CKD (any stage)</td>\\n<td>19,758 (42.0)</td>\\n<td>44,280 (58.9)</td>\\n<td>5082 (55.9)</td>\\n</tr>\\n<tr>\\n<td>Diabetes mellitus</td>\\n<td>23,059 (49.1)</td>\\n<td>44,900 (59.8)</td>\\n<td>3145 (34.6)</td>\\n</tr>\\n<tr>\\n<td>Hypertension</td>\\n<td>44,660 (95.0)</td>\\n<td>73,459 (97.8)</td>\\n<td>7837 (86.2)</td>\\n</tr>\\n<tr>\\n<td>Ischaemic heart disease</td>\\n<td>29,715 (63.2)</td>\\n<td>59,685 (79.4)</td>\\n<td>5174 (56.9)</td>\\n</tr>\\n<tr>\\n<td>Hyperkalaemia</td>\\n<td>2,195 (4.7)</td>\\n<td>12,000 (16.0)</td>\\n<td>1029 (11.3)</td>\\n</tr>\\n<tr>\\n<td>Stroke</td>\\n<td>4,747 (10.1)</td>\\n<td>10,136 (13.5)</td>\\n<td>1906 (21.0)</td>\\n</tr>\\n<tr>\\n<td>Venous thromboembolism</td>\\n<td>3,697 (7.9)</td>\\n<td>5105 (6.8)</td>\\n<td>1,047 (11.5)</td>\\n</tr>\\n<tr>\\n<td>Depression</td>\\n<td>13,255 (28.2)</td>\\n<td>21,057 (28.0)</td>\\n<td>639 (7.0)</td>\\n</tr>\\n<tr>\\n<td>Respiratory infection</td>\\n<td>13,616 (29.0)</td>\\n<td>36,697 (48.8)</td>\\n<td>3,711 (40.8)</td>\\n</tr>\\n<tr>\\n<td>Hypothyroidism</td>\\n<td>8,678 (18.5)</td>\\n<td>20,420 (27.2)</td>\\n<td>1,001 (11.0)</td>\\n</tr>\\n<tr>\\n<td>COPD</td>\\n<td>15,738 (33.5)</td>\\n<td>35,363 (47.1)</td>\\n<td>1711 (18.8)</td>\\n</tr>\\n<tr>\\n<td>Myocardial infarction</td>\\n<td>10,300 (21.9)</td>\\n<td>30,145 (40.1)</td>\\n<td>1798 (19.8)</td>\\n</tr>\\n<tr>\\n<td>Cancer</td>\\n<td>9604 (20.4)</td>\\n<td>11,763 (15.7)</td>\\n<td>2,091 (23.0)</td>\\n</tr>\\n</tbody>\\n</table>\\n</div>\\n<div></div>\\n</div>\\n<p>We apologize for this error.</p>\",\"PeriodicalId\":164,\"journal\":{\"name\":\"European Journal of Heart Failure\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":16.9000,\"publicationDate\":\"2024-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Heart Failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ejhf.3521\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ejhf.3521","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
A Alexander Michel 等人撰写的摘要 "心力衰竭恶化患者的住院时间、再住院率和合并症。特征德国 n = 47,003 美国 n = 75,140 日本 n = 9,091 平均年龄 (SD), 岁78.91 (10.02)74.24 (10.88)77.55 (10.02)Female n (%)23,756 (50.5)33,968 (45.2)4,084(44.9)男性23,247(49.5)41,132(54.7)5,007(55.1)合并症n(%)贫血10,297(21.9)38,313(51.0)3,120(34.3)心房颤动24,574(52.3)43,768(58.2)3571(39.3)慢性肾功能衰竭（任何阶段）19,758(42.0)44,280(58.9)5082(55.9)糖尿病23,059(49.1)44,900(59.8)3145(34.6)高血压44,660 (95.0)73,459 (97.8)7837 (86.2)缺血性心脏病29,715 (63.2)59,685 (79.4)5174 (56.9)高钾血症2,195 (4.7)12,000 (16.0)1029(11.3)中风4,747(10.1)10,136(13.5)1906(21.0)静脉血栓栓塞3,697(7.9)5105(6.8)1,047(11.5)抑郁症13,255(28.2)21,057(28.0)639(7.0)呼吸道感染13,616(29.0)36,697(48.8)3,711(40.8)甲状腺功能减退症8,678(18.5)20,420(27.2)1,001(11.0)慢性阻塞性肺病15,738(33.5)35,363(47.1)1711 (18.8)心肌梗塞10,300 (21.9)30,145 (40.1)1798 (19.8)癌症9604 (20.4)11,763 (15.7)2,091 (23.0)我们对这一错误表示歉意。
Correction to Abstracts of the Heart Failure 2024, 11-14 May 2024, Lisbon, Portugal. European Journal of Heart Failure. 26(Suppl. 2) (2024) 246-260. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3326
The table 1 in abstract “Length of hospital stay, re-hospitalization rates and comorbidities in patients with worsening heart failure. Data from 3 large cohort studies in the US, Germany and Japan” by A Alexander Michel, e. al. has been updated as follows.
期刊介绍：
European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
